Youth antipsychotic treatment heightens risk of diabetes, meta‐analysis finds

A meta‐analysis of 13 studies has found that youths exposed to antipsychotics have a significantly higher risk and prevalence of type 2 diabetes than healthy youths or youths with psychiatric illness but no antipsychotic exposure. Multivariable analyses examining individual second‐generation antipsychotics (SGAs) found that higher risk of type 2 diabetes was associated with a longer duration of follow‐up, prescription of olanzapine, and male gender. Results were published online Jan. 20 in JAMA Psychiatry.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Adverse Events Source Type: research